Analysts Viewpoint
SAVA Stock Sees Decline of Approximately -0.49% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Cassava Sciences Inc revealed its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Cassava Sciences, Inc. (SAVA) has seen a push of 7.26% in the aftermarket because the company announced that petition filed
U.S. stocks posted broad declines yesterday as investors grew cautious in the wake of Fed Chairman Jay Powell’s Wednesday comments
The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a